MDMA fundamentals
An in-depth look to PHARMALA BIOTECH HOLDINGS INC. operating, investing, and financing activities
MDMA free cash flow for Q2 24 is -106.6 k CAD. For 2023, MDMA free cash flow was -339.66 k CAD and operating cash flow was -339.66 k CAD.
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CAD
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM